Below are a few of the most common questions about ColoPrint. Click on a question below to learn more.
ColoPrint is appropriate for men and women with newly diagnosed stage II colon cancer.
Only a licensed healthcare professional, such as your physician, may order the test. You can ask your doctor if the ColoPrint test is appropriate for you.
The ColoPrint test is performed on a small piece of tumor tissue that was removed during your surgery. The tissue is sent to the pathologist in the hospital where you had your surgery. When your doctor orders the ColoPrint test, the pathologist prepares two small samples of the tumor tissue for Agendia. Agendia performs the ColoPrint test and provides a result report to your doctor. You do not have to go through an additional procedure to get the ColoPrint test.
It is important to know that ColoPrint is performed on a fresh biopsy specimen. Therefore you should let your doctor know before surgery that you would like a ColoPrint test performed after surgery. Your doctor can then order a ColoPrint specimen collection kit and inform the pathologist that small pieces of your tumor will be used for the test. The specimen collection kit contains all material and instructions necessary for your doctor to take a sample and order the ColoPrint test for you.
Agendia operates CAP/CLIA licensed and compliant, FDA registered/compliant laboratories in Amsterdam, and Irvine, California.
ColoPrint provides information about the specific genomic profile of your tumor and indicates if you have a Low or High Risk that the tumor might come back. These results can provide valuable information to you and your physician to make a more informed, individualized treatment decision.
The ordering physician typically receives the result report about 10 days after Agendia receives the specimen. The results are typically discussed during an office visit with your doctor.
Our mission is to ensure all cancer patients have access to important, and clinically relevant molecular diagnostic testing empowering patients and physicians to make the most informed treatment decisions. Agendia understands that costs associated with a patient’s diagnosis, treatment, and management of colon cancer can potentially pose a financial hardship which may influence a patient’s decision in selecting diagnostic and treatment options. Please contact a Patient Advocate for information about your specific coverage. They can be reached at 888.363.7868 or email at firstname.lastname@example.org
Agendia is a compassionate company offering a wide range of financial assistance programs based on individual financial status. Agendia offers the following programs to meet your financial needs:
For more information, or to speak with a Patient Advocate Representative, call us at 888.363.7868 or email at email@example.com
Many insurance carriers cover most types of genomic testing for breast cancer. Like each patient, every case is unique, and the average out-of-pocket amount varies based on: insurance benefits, what portion of your deductible has been met and your co-pay amounts. If you have active insurance coverage at the time of testing, Agendia can provide you with an estimate of your financial responsibility based on your specific benefit levels. Please call 888.363.7868 and one of our Patient Advocate Representatives will gladly assist you.